Marinos C Dalakas Selected Research

Inclusion Body Myositis

1/2022	Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits.
12/2020	Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications.
1/2019	Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis.
4/2016	Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.
9/2015	HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis.
7/2015	Treatment for inclusion body myositis.
7/2014	Mechanistic effects of IVIg in neuroinflammatory diseases: conclusions based on clinicopathologic correlations.
11/2013	The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot study.
12/2012	Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and β-amyloid in the muscle.
4/2012	Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marinos C Dalakas Research Topics

Disease

28	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2022 - 05/2004
26	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 06/2003
26	Inclusion Body Myositis 01/2022 - 06/2003
26	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2022 - 12/2002
21	Myasthenia Gravis 01/2022 - 05/2004
20	Dermatomyositis (Dermatopolymyositis) 01/2022 - 06/2003
19	Polyneuropathies (Polyneuropathy) 01/2022 - 05/2004
14	Inflammation (Inflammations) 04/2016 - 08/2003
13	Muscular Diseases (Myopathy) 01/2022 - 03/2003
11	Nervous System Diseases (Neurological Disorders) 01/2022 - 12/2005
10	Guillain-Barre Syndrome 01/2022 - 06/2002
9	Multiple Sclerosis 01/2022 - 05/2004
8	Polymyositis 12/2020 - 09/2003
8	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 01/2006
7	Disease Progression 01/2022 - 08/2006
6	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2022 - 11/2013
6	Central Nervous System Diseases (CNS Diseases) 01/2022 - 05/2005
5	Spasm (Spasms) 01/2022 - 06/2005
5	Epilepsy (Aura) 01/2022 - 11/2013
5	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 12/2002
5	Cerebellar Ataxia (Dysmetria) 01/2022 - 11/2013
5	Autoimmune Diseases of the Nervous System 01/2022 - 12/2014
5	COVID-19 01/2022 - 01/2020
5	Fibrosis (Cirrhosis) 01/2022 - 08/2005
5	Neuroinflammatory Diseases 11/2020 - 09/2006
5	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020 - 09/2006
5	Muscle Weakness 01/2020 - 02/2004
5	Neuromyelitis Optica (Devic's Disease) 12/2015 - 10/2006
5	Nonaka type Distal myopathy 03/2007 - 03/2004
4	Infections 01/2020 - 01/2015
4	Ataxia (Dyssynergia) 11/2019 - 03/2010
4	Neoplasms (Cancer) 11/2019 - 04/2011
4	Muscular Dystrophies (Muscular Dystrophy) 09/2015 - 02/2004
3	Deglutition Disorders (Dysphagia) 01/2022 - 11/2008
3	Fatigue 10/2021 - 04/2013
3	Alzheimer Disease (Alzheimer's Disease) 11/2020 - 09/2006
3	Brain Diseases (Brain Disorder) 11/2020 - 01/2018
3	Virus Diseases (Viral Diseases) 11/2019 - 04/2011
3	Pain (Aches) 01/2018 - 02/2005
3	Paraproteinemias (Monoclonal Gammopathy) 01/2018 - 01/2006
3	Relapsing-Remitting Multiple Sclerosis 01/2018 - 10/2008
2	Isaacs Syndrome (Neuromyotonia) 01/2022 - 01/2022
2	Amyloid Plaque 01/2022 - 11/2013
2	Necrosis 01/2022 - 09/2003
2	Common Cold 10/2021 - 01/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2020 - 10/2006
2	Coma (Comas) 11/2020 - 11/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 12/2005
2	Thymoma (Thymic Carcinoma) 11/2019 - 12/2014
2	Seizures (Absence Seizure) 01/2018 - 01/2013
2	Experimental Autoimmune Neuritis 01/2018 - 06/2013
2	Headache (Headaches) 01/2018 - 09/2010
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2017 - 09/2006
2	Optic Neuritis (Retrobulbar Neuritis) 08/2015 - 05/2004

Drug/Important Bio-Agent (IBA)

41	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 06/2002
36	AntibodiesIBA 01/2022 - 12/2002
22	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
19	AutoantibodiesIBA 01/2022 - 06/2004
16	Complement System Proteins (Complement)IBA 01/2022 - 09/2003
13	AntigensIBA 11/2019 - 06/2004
11	Amyloid (Amyloid Fibrils)IBA 01/2022 - 10/2004
10	Immunoglobulin G (IgG)IBA 01/2022 - 01/2013
10	CytokinesIBA 11/2020 - 12/2002
8	Rituximab (Mabthera)FDA Link 01/2022 - 10/2008
8	Monoclonal AntibodiesIBA 01/2022 - 08/2006
6	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2022 - 06/2004
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2006
6	DesminIBA 07/2009 - 03/2003
5	gamma-Aminobutyric Acid (GABA)IBA 01/2022 - 06/2005
5	Biological ProductsIBA 01/2022 - 08/2005
5	Immunoglobulin M (IgM)IBA 01/2018 - 06/2004
5	CaprylatesIBA 02/2012 - 02/2008
4	Cholinergic ReceptorsIBA 01/2022 - 12/2012
4	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2020 - 03/2004
4	IceIBA 01/2019 - 02/2008
4	Messenger RNA (mRNA)IBA 09/2015 - 05/2004
4	SteroidsIBA 08/2015 - 06/2003
4	Amyloid beta-PeptidesIBA 05/2008 - 10/2004
4	ChemokinesIBA 05/2008 - 08/2003
4	EnzymesIBA 12/2006 - 03/2004
3	Phosphotransferases (Kinase)IBA 01/2022 - 11/2005
3	Peptides (Polypeptides)IBA 10/2021 - 01/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 03/2006
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2016 - 06/2003
3	Immunoglobulins (Immunoglobulin)IBA 07/2014 - 05/2009
3	Myelin-Associated GlycoproteinIBA 05/2012 - 05/2004
3	Pharmaceutical PreparationsIBA 10/2011 - 03/2010
2	Ligases (Synthetase)IBA 01/2022 - 12/2020
2	muskIBA 01/2022 - 10/2020
2	Contactin 1IBA 01/2022 - 01/2022
2	Immunoglobulin Fc FragmentsIBA 10/2020 - 11/2015
2	Antiviral Agents (Antivirals)IBA 11/2019 - 01/2018
2	Methotrexate (Mexate)FDA LinkGeneric 07/2015 - 05/2012
2	EpitopesIBA 01/2015 - 12/2005
2	Reverse Transcriptase InhibitorsIBA 04/2013 - 04/2013
2	NucleosidesIBA 04/2013 - 04/2013

Therapy/Procedure

43	Therapeutics 01/2022 - 12/2002
17	Immunotherapy 01/2022 - 05/2005
3	Plasmapheresis 03/2015 - 06/2011
2	Art Therapy 01/2016 - 06/2012